Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1971 1
1972 5
1973 8
1974 4
1975 5
1976 6
1977 5
1978 10
1979 8
1980 10
1981 17
1982 12
1983 15
1984 4
1985 10
1986 13
1987 7
1988 17
1989 6
1990 10
1991 9
1992 6
1993 10
1994 11
1995 10
1996 12
1997 6
1998 17
1999 6
2000 15
2001 10
2002 8
2003 11
2004 8
2005 6
2006 8
2007 13
2008 11
2009 9
2010 8
2011 10
2012 10
2013 12
2014 8
2015 11
2016 11
2017 5
2018 7
2019 4
2020 6
2021 6
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW. Diabetic Retinopathy Clinical Research Network, et al. N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264. Epub 2015 Feb 18. N Engl J Med. 2015. PMID: 25692915 Free PMC article. Clinical Trial.
The kynurenine pathway: Towards metabolic equilibrium.
Clarke G, Stone TW, Schwarcz R. Clarke G, et al. Among authors: stone tw. Neuropharmacology. 2017 Jan;112(Pt B):235-236. doi: 10.1016/j.neuropharm.2016.08.029. Epub 2016 Aug 24. Neuropharmacology. 2017. PMID: 27567943 No abstract available.
LAT1 enables T cell activation under inflammatory conditions.
Ogbechi J, Wright HL, Balint S, Topping LM, Kristina Z, Huang YS, Pantazi E, Swart M, Windell D, Marin E, Wempe MF, Endou H, Thomas AM, Filer A, Stone TW, Clarke AJ, Dustin ML, Williams RO. Ogbechi J, et al. Among authors: stone tw. J Autoimmun. 2023 Jul;138:103031. doi: 10.1016/j.jaut.2023.103031. Epub 2023 May 23. J Autoimmun. 2023. PMID: 37229811
IDO activation, inflammation and musculoskeletal disease.
Ogbechi J, Clanchy FI, Huang YS, Topping LM, Stone TW, Williams RO. Ogbechi J, et al. Among authors: stone tw. Exp Gerontol. 2020 Mar;131:110820. doi: 10.1016/j.exger.2019.110820. Epub 2019 Dec 26. Exp Gerontol. 2020. PMID: 31884118 Review.
TNFR2 signalling in inflammatory diseases.
Williams RO, Clanchy FI, Huang YS, Tseng WY, Stone TW. Williams RO, et al. Among authors: stone tw. Best Pract Res Clin Rheumatol. 2024 Mar 26:101941. doi: 10.1016/j.berh.2024.101941. Online ahead of print. Best Pract Res Clin Rheumatol. 2024. PMID: 38538489 Review.
Integrative Pharmacology in the Treatment of Substance Use Disorders.
Donlon J, Kumari P, Varghese SP, Bai M, Florentin OD, Frost ED, Banks J, Vadlapatla N, Kam O, Shad MU, Rahman S, Abulseoud OA, Stone TW, Koola MM. Donlon J, et al. Among authors: stone tw. J Dual Diagn. 2024 Apr-Jun;20(2):132-177. doi: 10.1080/15504263.2023.2293854. Epub 2023 Dec 20. J Dual Diagn. 2024. PMID: 38117676 Review.
453 results